IONIS PHARMACEUTICALS INC Balance Sheet
IONS / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
IONIS PHARMACEUTICALS INC had $3.5B in total assets and $489M in shareholders' equity as of FY2025. Total debt was $1.8B against $372M in cash, resulting in $1.4B net debt.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $372.3M | $242.1M | $399.3M | $276.5M | $869.2M | $397.7M | $683.3M | $278.8M | $129.6M | $84.7M | $128.8M | $124.5M | $65.5M | $70.1M | $65.5M |
| Inventory | $10.0M | $12.5M | $7.4M | $22.0M | $24.8M | $22.0M | $18.2M | $8.6M | $10.0M | - | - | - | - | - | - |
| Current Assets | $3.0B | $2.6B | $2.6B | $2.2B | $2.3B | $2.1B | $2.7B | $2.2B | $1.2B | $797.9M | $837.0M | $836.6M | $735.5M | $423.4M | $360.1M |
| PP&E (Net) | $123.0M | $94.3M | $71.0M | $74.3M | $178.1M | $181.1M | $153.7M | $132.2M | $121.9M | $92.8M | $90.2M | $89.0M | $86.2M | $91.1M | $96.6M |
| Total Assets | $3.5B | $3.0B | $3.0B | $2.5B | $2.6B | $2.4B | $3.2B | $2.7B | $1.3B | $912.5M | $947.9M | $955.8M | $847.2M | $545.7M | $484.9M |
| Current Liabilities | $781.6M | $309.3M | $448.1M | $311.6M | $240.6M | $583.3M | $273.0M | $280.3M | $243.6M | $133.8M | $148.9M | $115.3M | $97.8M | $74.3M | $76.1M |
| Total Debt | $1.8B | $1.3B | $1.3B | $1.2B | - | - | - | - | - | - | - | - | - | - | - |
| Shareholders' Equity | $489.1M | $588.4M | $386.7M | $572.9M | $743.3M | $843.3M | $1.5B | $1.0B | $281.0M | $99.6M | $200.8M | $257.8M | $378.4M | $182.8M | $171.4M |